Neurobehavioral Impacts of the Autism Risk Gene, WAC: Studies Involving C. elegans and Mice.

Researchers studied a gene called WAC that may be linked to autism. Using worms and mice, they found that when this gene is deleted, it changes how brain chemicals work, particularly affecting movement and behavior. The study helps us understand how certain genetic changes might contribute to autism symptoms.

This preclinical study investigated the WAC gene's role in autism spectrum disorder using C. elegans worms and mouse models. WAC gene deletion led to enhanced acetylcholine-associated behaviors through increased nicotinic acetylcholine receptor activity, along with reduced motility and altered dopamine behaviors in worms. Key genes including lev-1 were upregulated. In mouse cortical tissue, an inverse relationship between Wac expression and CHRNA7 levels was observed, though direct CHRNA7 expression differences weren't significant compared to controls.

The research suggests WAC gene deletion affects multiple neurotransmitter systems, providing insights into potential mechanisms linking WAC mutations to neurodevelopmental disorders including ASD.

Provides preliminary insights into WAC gene's role in neurotransmitter function relevant to autism. May inform future research directions but requires human validation. Findings are too early-stage to directly influence clinical practice or therapeutic development.

Study uses animal models (C. elegans and mice) which may not fully translate to human autism. Sample sizes not reported. Direct human relevance unclear. Mechanisms identified may not represent the complexity of human ASD neurobiology.

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by a broad spectrum of behavioral impairments. While multiple genetic and environmental factors are attributed to its cause, biological underpinnings are still poorly understood. The WAC gene has been primarily linked with DeSanto-Shinawi syndrome, a rare neurodevelopmental disorder. Due to overlapping manifestations, studies on WAC gene and its potential role in ASD have recently gained traction.

This study elucidates effects of WAC deletion and characterizes the findings and mechanisms vis-à-vis relevant neural aberrations in ASD. Mutant Caenorhabditis elegans (wac-1.1and wac-1.2) showed enhanced acetylcholine-associated behavior, as indicated by the aldicarb assay, without any alteration in acetylcholine levels or acetylcholinesterase activity. Upon further investigation, we found that the elevated cholinergic transmission resulted from increased activity of nicotinic acetylcholine receptors (nAChRs). Additionally, we observed reduced motility and dopamine-associated behaviors.

Several key genes were upmodulated including lev-1. Notably, lev-1 RNAi did not alter the enhanced cholinergic transmission, suggesting an involvement of multiple players in enhanced cholinergic signaling. Upon further validation in cortical tissue of Wacmice, no significant difference in CHRNA7 expression was observed compared with WT controls. Although genetic compensation and expression variation in Wacmice and wild-type mice respectively was observed, in general, an inversely proportionate correlation between Wac mRNA expression and CHRNA7 levels was observed.

Overall, these studies indicate alterations in multiple neurotransmitter-associated behaviors result from WAC-gene deletion. Our findings are a step forward in addressing informational gaps with respect to the WAC and ASD.